Dyslexia-associated protein KIAA0319 (KIAA0319)

KIAA0319 is a type I transmembrane protein highly expressed in the developing human brain, specifically implicated in reading ability and neuronal migration[5][3][4][1][7]. It is characterized by a large, highly glycosylated extracellular domain containing five polycystic kidney disease (PKD) domains, which likely mediate cell–cell or cell–matrix adhesion, analogous to proteins such as polycystin-1[5][7]. KIAA0319 regulates the transition of neuroepithelial cells to neuronal progenitors and is critical for proper cortical neurogenesis and cell cycle regulation in early brain development[1]. It undergoes ectodomain shedding and intramembrane cleavage, generating fragments with possible nuclear signaling roles, although the functional significance of these fragments remains unclear[3]. Genetic variants in its promoter modulate expression during neurodevelopment and are robustly associated with developmental dyslexia across populations[1][6]. Experimental models suggest the protein may regulate cilia biology, cell migration, cellular adhesion, and mechanosensory functions[7]. However, KIAA0319 is not currently considered a therapeutic target (e.g., for pharmacological intervention), and no drugs are known to interact with it. Essential context: - KIAA0319 is sometimes mistakenly grouped with canonical receptors or enzymes but is best classified as a neuronal migration gene or cell adhesion molecule, not a conventional drug target[5][7]. - Its main role in disease is as a *susceptibility gene* for developmental dyslexia, not as a classical "therapeutic target," and at present no drugs act directly on it. - Variants in KIAA0319 are considered *risk biomarkers* for dyslexia, but KIAA0319 is not used as a predictive or response biomarker for therapy[1][6]. - There is no evidence the gene/protein is misspelled in this context, and the descriptions align with the established literature.

Other names

Dyslexia-associated protein KIAA0319NMIGDYLX2DYX2dyslexia susceptibility 2neuronal migration geneKIAA0319

Not applicable (no approved drugs or inhibitors directly targeting this protein)